CAMP4 Therapeutics (NASDAQ:CAMP) Director Andrew Schwab Sells 400,000 Shares

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Director Andrew Schwab sold 400,000 shares of CAMP4 Therapeutics stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $4.04, for a total value of $1,616,000.00. Following the sale, the director directly owned 2,033,270 shares in the company, valued at $8,214,410.80. The trade was a 16.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

CAMP4 Therapeutics Trading Down 4.6%

Shares of NASDAQ CAMP opened at $3.96 on Tuesday. The firm has a market capitalization of $248.49 million, a price-to-earnings ratio of -1.71 and a beta of 0.22. CAMP4 Therapeutics Corporation has a one year low of $1.41 and a one year high of $7.75. The business has a fifty day simple moving average of $4.13 and a 200 day simple moving average of $4.35.

CAMP4 Therapeutics (NASDAQ:CAMP) last posted its quarterly earnings results on Thursday, August 13th. The Wireless communications provider reported ($0.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.34). CAMP4 Therapeutics had a negative return on equity of 252.79% and a negative net margin of 2,543.74%.The business had revenue of $1.78 million for the quarter. On average, research analysts anticipate that CAMP4 Therapeutics Corporation will post -0.57 earnings per share for the current fiscal year.

Institutional Trading of CAMP4 Therapeutics

Several hedge funds have recently modified their holdings of CAMP. Jefferies Financial Group Inc. acquired a new position in shares of CAMP4 Therapeutics in the 4th quarter worth approximately $70,000. State Street Corp increased its holdings in CAMP4 Therapeutics by 52.7% during the 4th quarter. State Street Corp now owns 39,700 shares of the Wireless communications provider’s stock valued at $243,000 after purchasing an additional 13,700 shares in the last quarter. Bank of America Corp DE bought a new position in CAMP4 Therapeutics in the 4th quarter valued at $86,000. OMERS ADMINISTRATION Corp acquired a new position in CAMP4 Therapeutics in the fourth quarter worth $115,000. Finally, Goldman Sachs Group Inc. bought a new stake in shares of CAMP4 Therapeutics during the fourth quarter worth $115,000.

Analyst Ratings Changes

A number of research analysts have commented on CAMP shares. Piper Sandler restated an “overweight” rating and set a $15.00 price target (up from $12.00) on shares of CAMP4 Therapeutics in a research note on Friday, August 14th. Chardan Capital set a $6.50 price objective on CAMP4 Therapeutics and gave the company a “buy” rating in a research note on Wednesday, June 10th. UBS Group set a $15.00 target price on CAMP4 Therapeutics in a report on Friday, August 14th. Weiss Ratings upgraded CAMP4 Therapeutics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 14th. Finally, JPMorgan Chase & Co. raised CAMP4 Therapeutics from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $5.00 to $9.00 in a research note on Tuesday, June 16th. Seven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $9.56.

About CAMP4 Therapeutics

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location.